ImmunoCAP Tryptase Test Unique Marker of Severe Reactions/Mastocytosis
These products may not be cleared for use in your country. Please contact your sales representative for information about specific product availability.
本ページの製品は、薬事未承認品のため、日本での取り扱いはありません。
ImmunoCAP™ Tryptase is a unique marker that measures the total level of tryptase released by mast cells into circulation. Elevated tryptase levels help clinicians confirm mast cell activation during a severe allergic reaction, to decide if venom immunotherapy (VIT) is appropriate and to support the diagnosis of mastocytosis.1-3 ImmunoCAP Tryptase enables the measurement of transient increases in the level of tryptase as well as the establishment of the person’s baseline tryptase level. A transient increase of tryptase during a severe reaction helps to identify and assess the extent of the reaction.1 A persistent elevated baseline level of tryptase is an indication of possible mastocytosis.1,3
ImmunoCAP Tryptase testing in addition to clinical findings can help healthcare providers make:
Accurate diagnosis
- Severe reaction: Tryptase testing and relevant, specific IgE antibody testing, help identify if the underlying cause of the severe reaction is an allergy.4,5
- Mastocytosis: Tryptase baseline levels reflect the mast cell burden in the body and can help to rule in or rule out systemic mastocytosis.1,3
Assessment of risk
- An elevated baseline tryptase level may be a significant risk factor for repeated severe reactions to Hymenoptera insect stings and drugs, in conjunction with other clinical findings.2,4,5
Relevant treatment decisions
- Help decide if VIT is appropriate for patients with previous reactions to bee and/or wasp stings.2,4,5
- Decide on lifelong treatment for venom allergic patients with underlying mastocytosis.2,4,5
- Schwartz, L.B., Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am, 2006. 26(3): p. 451-63.
- Bonifazi, F., et al., Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy, 2005. 60(12): p. 1459-70.
- Horny H-P et al. Mastocytosis. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (Eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th edition). IARC: Lyon, 2017. .
- Simons, F.E., et al., International consensus on (ICON) anaphylaxis. World Allergy Organ J, 2014. 7(1): p. 9.
- Simons, F.E., et al., 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines. World Allergy Organ J, 2015. 8(1): p. 32.
